Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
A Single-Blind, Randomized, Placebo Controlled, Ascending Single and Repeat Dose Study with Once Daily Dosing to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK376501 and to Evaluate Food Effects and the Relative Bioavailability of a Tablet Formulation Compared to the Powder for Reconstitution Formulation in Healthy Overweight and Obese Subjects (DIX109177)
Age
18–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Inclusion:
Healthy
Non-smoking
Overweight or obese subjects with a BMI between 27 and 35.
Exclusion:
Women who are pregnant, lactating, or are of child-bearing potential